Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants

出版年份 2019 全文链接

标题

作者

关键词

出版物

Volume -, Issue -, Pages -

出版商

Elsevier BV

发表日期

2019-09-19

DOI

10.1016/j.ccell.2019.08.004

Discuss science. Find collaborators. Network.

Join a conversation

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now